Introduction. Protocols based on a content validated^1,2 algorithm^3* of wound care guided by valid patient risk and wound assessment scales reduce pressure ulcer incidence⁴ and improve acute and chronic^4-6 wound outcomes while reducing costs of care.^4-6 The value of rigorously adhering to a product formulary when using such a protocol is often questioned. Purpose. Summarize effects on wound care outcomes achieved using or not using specified product formularies within standardized protocols of care derived from a content validated wound care algorithm³. Method. A systematic review was conducted of clinical studies published using standardized wound care protocols based on a content-validated algorithm³. Reported outcomes for subjects managed using the specified protocol formulary were compared with those obtained using products not normally on-formulary. Results. Five studies^{2, 4-7} of more than 1310 chronic and 158 acute wounds, were identified in the literature search. Using the evidence-based product formulary* was associated with faster pressure ulcer healing⁷. A prospective comparative study⁶ reported improved pressure ulcer status as measured by PSST (Pressure Sore Status Tool) scores (p=0.046) and reduced costs of care (p<0.005) in pressure ulcers managed with primary dressings normally specified in the standardized protocol compared to using the same protocol with gauze-based primary dressings. Conclusions. Using evidence-based products within standardized protocols derived better, more economical wound outcomes than using off-protocol wound care products within the same protocols of care.

Notations

* Products specified in the standardized Solutions® protocol (Accessible at National Guideline Clearinghouse: www.guideline.gov) formulary included mainly DuoDERM®, AQUACEL® or KALTOSTAT® [ConvaTec] primary wound dressings or Aloe Vesta® 2-n-1 [ConvaTec] skin care products, in addition to appropriate measures to reduce risk factors for developing chronic ulcers. Non-protocol products included mainly gauze or impregnated gauze.

Solutions, DuoDERM, AQUACEL, KALTOSTAT and Aloe Vesta are registered trademarks of E. R. Squibb & Sons, L.L.C.